These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17541990

  • 1. Are MAP kinases drug targets? Yes, but difficult ones.
    Margutti S, Laufer SA.
    ChemMedChem; 2007 Aug; 2(8):1116-40. PubMed ID: 17541990
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase inhibitors: insights into drug design from structure.
    Noble ME, Endicott JA, Johnson LN.
    Science; 2004 Mar 19; 303(5665):1800-5. PubMed ID: 15031492
    [Abstract] [Full Text] [Related]

  • 3. Protein kinase inhibitors as a therapeutic modality.
    Levitzki A.
    Acc Chem Res; 2003 Jun 19; 36(6):462-9. PubMed ID: 12809533
    [Abstract] [Full Text] [Related]

  • 4. Protein kinase inhibitors from the urea class.
    Dumas J.
    Curr Opin Drug Discov Devel; 2002 Sep 19; 5(5):718-27. PubMed ID: 12630292
    [Abstract] [Full Text] [Related]

  • 5. Chemical genetic approaches to kinase drug discovery.
    Gallion SL, Qian D.
    Curr Opin Drug Discov Devel; 2005 Sep 19; 8(5):638-45. PubMed ID: 16159026
    [Abstract] [Full Text] [Related]

  • 6. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep 19; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 7. Development of Src tyrosine kinase substrate binding site inhibitors.
    Ye G, Tiwari R, Parang K.
    Curr Opin Investig Drugs; 2008 Jun 19; 9(6):605-13. PubMed ID: 18516760
    [Abstract] [Full Text] [Related]

  • 8. Targeting cancer with small-molecular-weight kinase inhibitors.
    Fabbro D, Cowan-Jacob SW, Möbitz H, Martiny-Baron G.
    Methods Mol Biol; 2012 Jun 19; 795():1-34. PubMed ID: 21960212
    [Abstract] [Full Text] [Related]

  • 9. High-throughput screening for kinase inhibitors.
    von Ahsen O, Bömer U.
    Chembiochem; 2005 Mar 19; 6(3):481-90. PubMed ID: 15742384
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of protein-protein interactions using designed molecules.
    Wilson AJ.
    Chem Soc Rev; 2009 Dec 19; 38(12):3289-300. PubMed ID: 20449049
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protein kinase inhibitors--potential chemotherapeutic agents.
    Shugar D.
    Acta Biochim Pol; 1995 Dec 19; 42(4):405-18. PubMed ID: 8852331
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Compartmentalised MAPK pathways.
    Brown MD, Sacks DB.
    Handb Exp Pharmacol; 2008 Dec 19; (186):205-35. PubMed ID: 18491054
    [Abstract] [Full Text] [Related]

  • 20. Kinase inhibitors in cancer therapy.
    London C.
    Vet Comp Oncol; 2004 Dec 19; 2(4):177-93. PubMed ID: 19379292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.